Dermata Therapeutics Stock Forward View - Accumulation Distribution
| DRMAW Stock | USD 0.02 0 14.95% |
Dermata Stock outlook is based on your current time horizon.
At this time the rsi of Dermata Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Dermata Therapeutics hype-based prediction, you can estimate the value of Dermata Therapeutics Warrant from the perspective of Dermata Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Dermata Therapeutics after-hype prediction price | USD 0.02 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Dermata Therapeutics to cross-verify your projections. Dermata Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dermata price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dermata using various technical indicators. When you analyze Dermata charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 1128.27 | 2676.35 |
| Check Dermata Therapeutics Volatility | Backtest Dermata Therapeutics | Information Ratio |
Dermata Therapeutics Trading Date Momentum
| On February 09 2026 Dermata Therapeutics Warrant was traded for 0.02 at the closing time. The highest daily price throughout the period was 0.02 and the lowest price was 0.01 . The daily volume was 11.1 K. The net trading volume on 02/09/2026 did not affect price variability. The overall trading delta to current closing price is 10.30% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Dermata Therapeutics to competition |
Other Forecasting Options for Dermata Therapeutics
For every potential investor in Dermata, whether a beginner or expert, Dermata Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dermata Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dermata. Basic forecasting techniques help filter out the noise by identifying Dermata Therapeutics' price trends.Dermata Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dermata Therapeutics stock to make a market-neutral strategy. Peer analysis of Dermata Therapeutics could also be used in its relative valuation, which is a method of valuing Dermata Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dermata Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dermata Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dermata Therapeutics shares will generate the highest return on investment. By undertsting and applying Dermata Therapeutics stock market strength indicators, traders can identify Dermata Therapeutics Warrant entry and exit signals to maximize returns.
| Accumulation Distribution | 2676.35 | |||
| Daily Balance Of Power | (0.62) | |||
| Rate Of Daily Change | 0.85 | |||
| Day Median Price | 0.0172 | |||
| Day Typical Price | 0.0169 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) |
Dermata Therapeutics Risk Indicators
The analysis of Dermata Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dermata Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dermata stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 10.39 | |||
| Semi Deviation | 12.79 | |||
| Standard Deviation | 14.84 | |||
| Variance | 220.22 | |||
| Downside Variance | 217.42 | |||
| Semi Variance | 163.47 | |||
| Expected Short fall | (12.43) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dermata Therapeutics
The number of cover stories for Dermata Therapeutics depends on current market conditions and Dermata Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dermata Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dermata Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Dermata Therapeutics Short Properties
Dermata Therapeutics' future price predictability will typically decrease when Dermata Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dermata Therapeutics Warrant often depends not only on the future outlook of the potential Dermata Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dermata Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 153 K | |
| Cash And Short Term Investments | 3.2 M |
Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.